Trillsch F, Mahner S, Ataseven B, Asher R, et al. Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study. Gynecol Oncol 2022 Jan 31. pii: S0090-8258(22)00050.
PMID: 35115180